Stay updated on scAAV9.U1a.hSGSH Gene Transfer Clinical Trial

Sign up to get notified when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has updated the details of a clinical trial for UX111, including the timeline for the administration of prophylactic immunomodulatory therapy, and has changed the contact email for a key individual involved in the trial.
    Difference
    2%
    Check dated 2025-02-24T22:35:20.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T15:28:54.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:52:27.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The website has updated the status of the Phase I/II/III Gene Transfer Clinical Trial of ScAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA to 'Completed' and provided new contact information for trial recruitment, while removing previous details about the trial's active status and certain assessment metrics.
    Difference
    4%
    Check dated 2025-01-20T02:13:46.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The study has shifted focus from evaluating the efficacy and safety of ABO-102 to UX111 for treating MPS IIIA, with significant updates including the introduction of adjuvant immunomodulatory therapy and detailed eligibility criteria for participants.
    Difference
    54%
    Check dated 2025-01-12T22:52:56.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:19:35.000Z thumbnail image

Stay in the know with updates to scAAV9.U1a.hSGSH Gene Transfer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.